{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:21:09Z","timestamp":1773836469354,"version":"3.50.1"},"reference-count":39,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7205","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T05:38:12Z","timestamp":1508305092000},"source":"Crossref","is-referenced-by-count":1,"title":["Alterations in expression levels of genes in p53\u2011related pathways determined using RNA\u2011Seq analysis in patients with breast cancer following CIK therapy"],"prefix":"10.3892","author":[{"given":"Zuowei","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Oncology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, Hubei 430022, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Wuhan University, Wuhan, Hubei 430072, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, Hubei 430022, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanglai","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, Hubei 430022, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, Hubei 430022, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Research, Wuhan Hamilton Biotechnology Co., Ltd., Wuhan, Hubei 430075, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Research, Wuhan Hamilton Biotechnology Co., Ltd., Wuhan, Hubei 430075, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Xiantao, Xiantao, Hubei 433000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Research, Wuhan Hamilton Biotechnology Co., Ltd., Wuhan, Hubei 430075, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongcheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Wuhan University, Wuhan, Hubei 430072, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"key20200714001235_b1-ol-0-0-7205","unstructured":"American Cancer Society: Cancer facts & figures2015https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2015\/cancer-facts-and-figures-2015.pdf"},{"key":"key20200714001235_b2-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual Report to the Nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"key":"key20200714001235_b3-ol-0-0-7205","first-page":"5","volume":"65","author":"Siegel","year":"2015","journal-title":"Cancer statistics, 2015: CA Cancer J Clin"},{"key":"key20200714001235_b4-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/tbj.12447","article-title":"Predictors of health care use of women with breast cancer: A systematic review","volume":"21","author":"Lo-Fo-Wong","year":"2015","journal-title":"Breast J"},{"key":"key20200714001235_b5-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"key20200714001235_b6-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/14653240903121252","article-title":"Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery","volume":"11","author":"Li","year":"2009","journal-title":"Cytotherapy"},{"key":"key20200714001235_b7-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1517\/14712598.2012.676037","article-title":"CIK cells-current status, clinical perspectives and future prospects-the good news","volume":"12","author":"Hui","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"key20200714001235_b8-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/14653249.2011.649185","article-title":"Cytokine-induced killer cells in the treatment of patients with solid carcinomas: A systematic review and pooled analysis","volume":"14","author":"Ma","year":"2012","journal-title":"Cytotherapy"},{"key":"key20200714001235_b9-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cellimm.2013.11.009","article-title":"Can the dual-functional capability of CIK cells be used to improve antitumor effects?","volume":"287","author":"Wang","year":"2014","journal-title":"Cell Immunol"},{"key":"key20200714001235_b10-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"key20200714001235_b11-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00018-003-3304-4","article-title":"The common and distinct target genes of the p53 family transcription factors","volume":"61","author":"Harms","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"key20200714001235_b12-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1158\/0008-5472.CAN-04-3835","article-title":"p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase","volume":"65","author":"Zhao","year":"2005","journal-title":"Cancer Res"},{"key":"key20200714001235_b13-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"key20200714001235_b14-ol-0-0-7205","unstructured":"MayoLDDonnerDBA phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleusProc Natl Acad Sci USA981159811603200110.1073\/pnas.18118119811504915"},{"key":"key20200714001235_b15-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis","volume":"21","author":"Gottlieb","year":"2002","journal-title":"Oncogene"},{"key":"key20200714001235_b16-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0006-2952(02)01149-8","article-title":"Regulation of p53: Intricate loops and delicate balances","volume":"64","author":"Oren","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20200714001235_b17-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"ijerph13010022","DOI":"10.3390\/ijerph13010022","article-title":"Hot spot mutation in TP53 (R248Q) causes oncogenic gain-of-function phenotypes in a breast cancer cell line derived from an African American patient","volume":"13","author":"Shtraizent","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"key20200714001235_b18-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fonc.2016.00007","article-title":"Clinical Overview of MDM2\/X-Targeted Therapies","volume":"6","author":"Burgess","year":"2016","journal-title":"Front Oncol"},{"key":"key20200714001235_b19-ol-0-0-7205","first-page":"3923","article-title":"Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients","volume":"6","author":"Alsner","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20200714001235_b20-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: One name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev"},{"key":"key20200714001235_b21-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","article-title":"The rebel angel: Mutant p53 as the driving oncogene in breast cancer","volume":"33","author":"Walerych","year":"2012","journal-title":"Carcinogenesis"},{"key":"key20200714001235_b22-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: New functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"key20200714001235_b23-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/carcin\/bgr270","article-title":"Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration","volume":"33","author":"Yeudall","year":"2012","journal-title":"Carcinogenesis"},{"key":"key20200714001235_b24-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"key20200714001235_b25-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1568009053332627","article-title":"MDM2 is a central node in the p53 pathway: 12 years and counting","volume":"5","author":"Bond","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"key20200714001235_b26-ol-0-0-7205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.1.2.1","article-title":"MDM2 and prognosis","volume":"2","author":"Onel","year":"2004","journal-title":"Mol Cancer Res"},{"key":"key20200714001235_b27-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.onc.1203468","article-title":"The loss of mdm2 induces p53-mediated apoptosis","volume":"19","author":"de Rozieres","year":"2000","journal-title":"Oncogene"},{"key":"key20200714001235_b28-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1074\/jbc.M305966200","article-title":"An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis","volume":"279","author":"Steinman","year":"2004","journal-title":"J Biol Chem"},{"key":"key20200714001235_b29-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1101\/gad.1662908","article-title":"The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss","volume":"22","author":"Terzian","year":"2008","journal-title":"Genes Dev"},{"key":"key20200714001235_b30-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714001235_b31-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fonc.2015.00284","article-title":"Regulation of Mutant p53 Protein Expression","volume":"5","author":"Vijayakumaran","year":"2015","journal-title":"Front Oncol"},{"key":"key20200714001235_b32-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: The growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"key20200714001235_b33-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.4161\/cc.5.23.3520","article-title":"Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML","volume":"5","author":"Kojima","year":"2006","journal-title":"Cell Cycle"},{"key":"key20200714001235_b34-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1091362","article-title":"Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2","volume":"302","author":"Li","year":"2003","journal-title":"Science"},{"key":"key20200714001235_b35-ol-0-0-7205","first-page":"88","article-title":"MDM2 and MDMX: Alone and together in regulation of p53","volume":"1","author":"Shadfan","year":"2012","journal-title":"Transl Cancer Res"},{"key":"key20200714001235_b36-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1074\/jbc.M115.644435","article-title":"The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization","volume":"290","author":"Leslie","year":"2015","journal-title":"J Biol Chem"},{"key":"key20200714001235_b37-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Brooks","year":"2006","journal-title":"Mol Cell"},{"key":"key20200714001235_b38-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/jmcb\/mju020","article-title":"microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network","volume":"6","author":"Hoffman","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"key20200714001235_b39-ol-0-0-7205","doi-asserted-by":"publisher","first-page":"e0152263","DOI":"10.1371\/journal.pone.0152263","article-title":"Mice with a Mutation in the Mdm2 gene that interferes with MDM2\/Ribosomal protein binding develop a defect in Erythropoiesis","volume":"11","author":"Kamio","year":"2016","journal-title":"PLoS One"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T20:24:35Z","timestamp":1659644675000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7205","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]}}}